OSE Immunotherapeutics SA banner

OSE Immunotherapeutics SA
F:6OP

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
F:6OP
Watchlist
Price: 3.638 EUR -3.6% Market Closed
Market Cap: €79.2m

Wall St Price Targets

6OP Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast 6OP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 6OP is 17.312 EUR with a low forecast of 13.261 EUR and a high forecast of 21.856 EUR.

Lowest Forecast
Price Target
13.261 EUR
265% Upside
Average Forecast
Price Target
17.312 EUR
376% Upside
Highest Forecast
Price Target
21.856 EUR
501% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
FLB
Fluidigm Corp
161% Upside

Revenue
Forecast

N/A
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is -41%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6OP's stock price target?
Price Target
17.312 EUR

According to Wall Street analysts, the average 1-year price target for 6OP is 17.312 EUR with a low forecast of 13.261 EUR and a high forecast of 21.856 EUR.

What is the Revenue forecast for OSE Immunotherapeutics SA?
Projected CAGR
-41%

The compound annual growth rate for Revenue over the next 3 years is -41%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett